Safranal Prevents Liver Cancer Through Inhibiting Oxidative Stress and Alleviating Inflammation

Despite all efforts, an effective and safe treatment for liver cancer remains elusive. Natural products and their derived biomolecules are potential resources to mine for novel anti-cancer drugs. Chemopreventive effects of safranal, a major bioactive ingredient of the golden spice “saffron”, were ev...

Full description

Bibliographic Details
Main Authors: Youssef Abdalla, Ali Abdalla, Alaaeldin Ahmed Hamza, Amr Amin
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-02-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2021.777500/full
_version_ 1818939615053086720
author Youssef Abdalla
Ali Abdalla
Alaaeldin Ahmed Hamza
Amr Amin
Amr Amin
author_facet Youssef Abdalla
Ali Abdalla
Alaaeldin Ahmed Hamza
Amr Amin
Amr Amin
author_sort Youssef Abdalla
collection DOAJ
description Despite all efforts, an effective and safe treatment for liver cancer remains elusive. Natural products and their derived biomolecules are potential resources to mine for novel anti-cancer drugs. Chemopreventive effects of safranal, a major bioactive ingredient of the golden spice “saffron”, were evaluated in this study against diethylnitrosamine (DEN)–induced liver cancer in rats. Safranal’s mechanisms of action were also investigated in the human liver cancer line “HepG2”. When administered to DEN-treated rats, safranal significantly inhibited proliferation (Ki-67) and also induced apoptosis (TUNEL and M30 CytoDeath). It also exhibited anti-inflammatory properties where inflammatory markers such as NF-kB, COX2, iNOS, TNF-alpha, and its receptor were significantly inhibited. Safranal’s in vivo effects were further supported in HepG2 cells where apoptosis was induced and inflammation was downregulated. In summary, safranal is reported here as a potent chemopreventive agent against hepatocellular carcinoma that may soon be an important ingredient of a broad-spectrum cancer therapy.
first_indexed 2024-12-20T06:26:33Z
format Article
id doaj.art-1d6d0381c0b5420ebbbecca3bedcc285
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-12-20T06:26:33Z
publishDate 2022-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-1d6d0381c0b5420ebbbecca3bedcc2852022-12-21T19:50:16ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122022-02-011210.3389/fphar.2021.777500777500Safranal Prevents Liver Cancer Through Inhibiting Oxidative Stress and Alleviating InflammationYoussef Abdalla0Ali Abdalla1Alaaeldin Ahmed Hamza2Amr Amin3Amr Amin4Department of Kinesiology, Michigan State University, East Lansing, MI, United StatesWeinberg Institute for Cognitive Science, University of Michigan, Ann Arbor, MI, United StatesHormone Evaluation Department, National Organization for Drug Control and Research, Giza, EgyptThe College, The University of Chicago, Chicago, IL, United StatesBiology Department, UAE University, Al Ain, United Arab EmiratesDespite all efforts, an effective and safe treatment for liver cancer remains elusive. Natural products and their derived biomolecules are potential resources to mine for novel anti-cancer drugs. Chemopreventive effects of safranal, a major bioactive ingredient of the golden spice “saffron”, were evaluated in this study against diethylnitrosamine (DEN)–induced liver cancer in rats. Safranal’s mechanisms of action were also investigated in the human liver cancer line “HepG2”. When administered to DEN-treated rats, safranal significantly inhibited proliferation (Ki-67) and also induced apoptosis (TUNEL and M30 CytoDeath). It also exhibited anti-inflammatory properties where inflammatory markers such as NF-kB, COX2, iNOS, TNF-alpha, and its receptor were significantly inhibited. Safranal’s in vivo effects were further supported in HepG2 cells where apoptosis was induced and inflammation was downregulated. In summary, safranal is reported here as a potent chemopreventive agent against hepatocellular carcinoma that may soon be an important ingredient of a broad-spectrum cancer therapy.https://www.frontiersin.org/articles/10.3389/fphar.2021.777500/fullliver cancerpreventionsafranaloxidative stressinflammation
spellingShingle Youssef Abdalla
Ali Abdalla
Alaaeldin Ahmed Hamza
Amr Amin
Amr Amin
Safranal Prevents Liver Cancer Through Inhibiting Oxidative Stress and Alleviating Inflammation
Frontiers in Pharmacology
liver cancer
prevention
safranal
oxidative stress
inflammation
title Safranal Prevents Liver Cancer Through Inhibiting Oxidative Stress and Alleviating Inflammation
title_full Safranal Prevents Liver Cancer Through Inhibiting Oxidative Stress and Alleviating Inflammation
title_fullStr Safranal Prevents Liver Cancer Through Inhibiting Oxidative Stress and Alleviating Inflammation
title_full_unstemmed Safranal Prevents Liver Cancer Through Inhibiting Oxidative Stress and Alleviating Inflammation
title_short Safranal Prevents Liver Cancer Through Inhibiting Oxidative Stress and Alleviating Inflammation
title_sort safranal prevents liver cancer through inhibiting oxidative stress and alleviating inflammation
topic liver cancer
prevention
safranal
oxidative stress
inflammation
url https://www.frontiersin.org/articles/10.3389/fphar.2021.777500/full
work_keys_str_mv AT youssefabdalla safranalpreventslivercancerthroughinhibitingoxidativestressandalleviatinginflammation
AT aliabdalla safranalpreventslivercancerthroughinhibitingoxidativestressandalleviatinginflammation
AT alaaeldinahmedhamza safranalpreventslivercancerthroughinhibitingoxidativestressandalleviatinginflammation
AT amramin safranalpreventslivercancerthroughinhibitingoxidativestressandalleviatinginflammation
AT amramin safranalpreventslivercancerthroughinhibitingoxidativestressandalleviatinginflammation